Early Visualization Assay of Neurodegenerative Diseases
First product able to detect misfolded proteins in live cells using small molecule fluorophores to quantify pre-fibril protein oligomers and insoluble protein aggregates in vitro and in vivo. AGlow kit will open new market opportunities by enabling researchers to determine how misfolded proteins contribute to disease, develop tools to diagnose associated diseases at a pre-symptomatic stage, and develop screens to generate novel therapeutic leads. -Xin Zhang, 2018 LB2C Recipient.
We work together with the Office of Technology Management (OTM) and the Office for Industrial Partnerships (OIP), engaging in assisting inventors in capturing Intellectual Property (IP), and providing academic resources and support to entrepreneurs.